EPTRUNAZ Trademark

Trademark Overview

On Tuesday, April 26, 2022, a trademark application was filed for EPTRUNAZ with the United States Patent and Trademark Office. The USPTO has given the EPTRUNAZ trademark a serial number of 97382974. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, June 5, 2024. This trademark is owned by Hikma Pharmaceuticals USA Inc.. The EPTRUNAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating anaphylaxis; pharmaceutical preparations exhibiting vasoconstricting, intraocular pressure-reducing, and bronchodilating activities, namely, pharmaceutical preparations for treating low blood pressure, intraocular pressure and broncho-constriction

General Information

Serial Number97382974
Word MarkEPTRUNAZ
Filing DateTuesday, April 26, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, June 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating anaphylaxis; pharmaceutical preparations exhibiting vasoconstricting, intraocular pressure-reducing, and bronchodilating activities, namely, pharmaceutical preparations for treating low blood pressure, intraocular pressure and broncho-constriction

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHikma Pharmaceuticals USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922
Party NameHikma Pharmaceuticals USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley Heights, NJ 07922

Trademark Events

Event DateEvent Description
Tuesday, September 13, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, April 29, 2022NEW APPLICATION ENTERED
Monday, May 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 6, 2022ASSIGNED TO EXAMINER
Tuesday, September 13, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, September 13, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 13, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, September 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 31, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2023SOU EXTENSION 1 FILED
Wednesday, May 31, 2023SOU EXTENSION 1 GRANTED
Friday, June 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 19, 2023SOU EXTENSION 2 FILED
Thursday, October 19, 2023SOU EXTENSION 2 GRANTED
Saturday, October 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 5, 2024SOU EXTENSION 3 FILED
Wednesday, June 5, 2024SOU EXTENSION 3 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 21, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 21, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 21, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

eptrunaz pharmaceutical pressure preparations treating intraocular namely blood constriction broncho activities